Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Amgen Fights to Keep Avacopan on Market Amid Growing Concerns

Summary by Medscape
NEJM’s retraction of the key avacopan paper reflects concerns about data used for approval of this autoimmune disease drug, which has been linked to liver injury. Medscape Medical News

1 Articles

MedscapeMedscape

Amgen Fights to Keep Avacopan on Market Amid Growing Concerns

NEJM’s retraction of the key avacopan paper reflects concerns about data used for approval of this autoimmune disease drug, which has been linked to liver injury. Medscape Medical News

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Medscape broke the news in United States on Friday, July 3, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Amgen icon

Amgen

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal